These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12188260)

  • 1. Imaging folate binding protein expression with MRI.
    Wiener EC; Konda SD; Wang S; Brechbiel M
    Acad Radiol; 2002 Aug; 9 Suppl 2():S316-9. PubMed ID: 12188260
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts.
    Konda SD; Aref M; Wang S; Brechbiel M; Wiener EC
    MAGMA; 2001 May; 12(2-3):104-13. PubMed ID: 11390265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress.
    Konda SD; Aref M; Brechbiel M; Wiener EC
    Invest Radiol; 2000 Jan; 35(1):50-7. PubMed ID: 10639036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts.
    Konda SD; Wang S; Brechbiel M; Wiener EC
    Invest Radiol; 2002 Apr; 37(4):199-204. PubMed ID: 11923642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal handling and physiologic effects of the paramagnetic contrast medium, gadolinium-DOTA.
    Katzberg RW; Sahler LG; Duda SW; Morris TW; McKenna BA; Pabico RC; Niedrach WL; Tonetti FW
    Invest Radiol; 1991 Nov; 26 Suppl 1():S129-30; discussion S137-8. PubMed ID: 1808108
    [No Abstract]   [Full Text] [Related]  

  • 6. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents.
    Tweedle MF
    Invest Radiol; 1992 Aug; 27 Suppl 1():S2-6. PubMed ID: 1506149
    [No Abstract]   [Full Text] [Related]  

  • 7. MR imaging of ovarian tumors using folate-receptor-targeted contrast agents.
    Wang ZJ; Boddington S; Wendland M; Meier R; Corot C; Daldrup-Link H
    Pediatr Radiol; 2008 May; 38(5):529-37. PubMed ID: 18357444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A step further in understanding the biology of the folate receptor in ovarian carcinoma.
    Bagnoli M; Canevari S; Figini M; Mezzanzanica D; Raspagliesi F; Tomassetti A; Miotti S
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S140-4. PubMed ID: 12586106
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcellular localisation of gadolinium in the rat brain.
    Allard M; Kien P; Caille JM; Bonnemain B; Doucet D; Simonnet G
    J Neuroradiol; 1987; 14(2):159-62. PubMed ID: 3681416
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
    Choi H; Choi SR; Zhou R; Kung HF; Chen IW
    Acad Radiol; 2004 Sep; 11(9):996-1004. PubMed ID: 15350580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of macrocyclic gadolinium chelates as hepatospecific MRI agents.
    Marinelli ER; Neubeck R; Song B; Wagler T; Ranganathan RS; Sukumaran K; Wedeking P; Nunn A; Runge V; Tweedle M
    Acad Radiol; 2002 May; 9 Suppl 1():S251-4. PubMed ID: 12019882
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo.
    Miotti S; Facheris P; Tomassetti A; Bottero F; Bottini C; Ottone F; Colnaghi MI; Bunni MA; Priest DG; Canevari S
    Int J Cancer; 1995 Nov; 63(3):395-401. PubMed ID: 7591238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in macrocyclic gadolinium complexes as magnetic resonance imaging contrast agents.
    Meyer D; Schaefer M; Doucet D
    Invest Radiol; 1990 Sep; 25 Suppl 1():S53-5. PubMed ID: 2132570
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)].
    Heuck A; Reiser M
    Internist (Berl); 1997 Dec; 38(12):1234-5. PubMed ID: 9465330
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing perfusion and capillary permeability changes induced by a VEGF inhibitor in human tumor xenografts using macromolecular MR imaging contrast media.
    Clément O; Pradel C; Siauve N; Frouin F; Bruneteau G; Kahn E; Frija G; Cuénod CA
    Acad Radiol; 2002 Aug; 9 Suppl 2():S328-9. PubMed ID: 12188264
    [No Abstract]   [Full Text] [Related]  

  • 17. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and chemical forms of gadolinium in the brain: a review.
    Kanda T; Nakai Y; Hagiwara A; Oba H; Toyoda K; Furui S
    Br J Radiol; 2017 Nov; 90(1079):20170115. PubMed ID: 28749164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful in vivo MRI tracking of MSCs labeled with Gadoteridol in a Spinal Cord Injury experimental model.
    Filippi M; Boido M; Pasquino C; Garello F; Boffa C; Terreno E
    Exp Neurol; 2016 Aug; 282():66-77. PubMed ID: 27212626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
    Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
    Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.